AVTRNYSELaboratory Analytical InstrumentsFiscal year ends December 31

Avantor, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 29, 2026

$16.29−0.13 (-0.79%)

Close on Oct 19, 2026

Market cap: $11.03B
P/E (TTM): –
Dividend yield: –

Dividends

Avantor has not reported a dividend

No dividend per share appears in Avantor's annual filings since fiscal 2016.

Where these numbers come from

Parsed from the XBRL in Avantor's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is AVTR.

Revenue growth-2.0% · median 6.9%

Gross margin32.1% · median 53.8%

Operating margin-4.5% · median 9.7%

Net margin-8.4% · median 8.6%

Company	Revenue	Growth
A	$7.37B	+8.6%
AVTR	$6.55B	-2.0%
WAT	$4.64B	+52.5%
MTD	$4.13B	+6.9%
RVTY	$2.91B	+4.1%
BIO	$2.59B	+1.4%

Company

Next earnings (est.): Oct 28, 2026, before open
Exchange: NYSE
Industry: Laboratory Analytical Instruments
Fiscal year ends: December 31
Employees: 13,500
Held by institutions: 100.0%
Auditor: Deloitte & Touche LLP
SEC CIK: 1722482

Advertisement
300 × 250